Contribution of Prostaglandin E2-Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood-Brain Barrier Crossing Celecoxib Derivative.

Shen CJ, Chen HC, Lin CL, Thakur A, Onuku R, Chen IC, Li HY, Chang KY, Chuang JY, Yang WB, Lin HY, Shen YR, Liou JP, Chang WC, Hsu TI

Open source

DOI
10.1002/advs.202506336
Published
2025 Oct
Container
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/advs.202506336,
  title = {Contribution of Prostaglandin E2-Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood-Brain Barrier Crossing Celecoxib Derivative.},
  author = {Shen CJ and Chen HC and Lin CL and Thakur A and Onuku R and Chen IC and Li HY and Chang KY and Chuang JY and Yang WB and Lin HY and Shen YR and Liou JP and Chang WC and Hsu TI},
  year = {2025},
  journal = {Advanced science (Weinheim, Baden-Wurttemberg, Germany)},
  doi = {10.1002/advs.202506336},
  url = {https://doi.org/10.1002/advs.202506336}
}

RIS

TY  - JOUR
TI  - Contribution of Prostaglandin E2-Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood-Brain Barrier Crossing Celecoxib Derivative.
AU  - Shen CJ
AU  - Chen HC
AU  - Lin CL
AU  - Thakur A
AU  - Onuku R
AU  - Chen IC
AU  - Li HY
AU  - Chang KY
AU  - Chuang JY
AU  - Yang WB
AU  - Lin HY
AU  - Shen YR
AU  - Liou JP
AU  - Chang WC
AU  - Hsu TI
PY  - 2025
JO  - Advanced science (Weinheim, Baden-Wurttemberg, Germany)
DO  - 10.1002/advs.202506336
UR  - https://doi.org/10.1002/advs.202506336
ER  - 

APA

CJ, S., HC, C., CL, L., A, T., R, O., IC, C., HY, L., KY, C., JY, C., WB, Y., HY, L., YR, S., JP, L., WC, C., & TI, H. (2025). Contribution of Prostaglandin E2-Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood-Brain Barrier Crossing Celecoxib Derivative.. Advanced science (Weinheim, Baden-Wurttemberg, Germany). https://doi.org/10.1002/advs.202506336

Source records